Kidney Week Educational Symposia-Advances in Treatment and Management of FSGS

Video Transcription

Video Summary

<strong style="box-sizing: border-box; font-weight: bold; color: #000000; font-family: 'Source Sans Pro', sans-serif; font-size: 14px; white-space: normal; background-color: #ffffff;">Moderator(s):</strong><span style="color: #000000; font-family: 'Source Sans Pro', sans-serif; font-size: 14px; white-space: normal; background-color: #ffffff; float: none; display: inline;"> Astrid Weins</span><br style="box-sizing: border-box; color: #000000; font-family: 'Source Sans Pro', sans-serif; font-size: 14px; white-space: normal; background-color: #ffffff;" /><br style="box-sizing: border-box; color: #000000; font-family: 'Source Sans Pro', sans-serif; font-size: 14px; white-space: normal; background-color: #ffffff;" /><strong style="box-sizing: border-box; font-weight: bold; color: #000000; font-family: 'Source Sans Pro', sans-serif; font-size: 14px; white-space: normal; background-color: #ffffff;">Presentation(s):</strong><br style="box-sizing: border-box; color: #000000; font-family: 'Source Sans Pro', sans-serif; font-size: 14px; white-space: normal; background-color: #ffffff;" />
<ul style="box-sizing: border-box; margin-top: 0px; margin-bottom: 10px; color: #000000; font-family: 'Source Sans Pro', sans-serif; font-size: 14px; white-space: normal; background-color: #ffffff;">
<li style="box-sizing: border-box;"><strong style="box-sizing: border-box; font-weight: bold;">Introduction</strong> - Astrid Weins</li>
<li style="box-sizing: border-box;"><strong style="box-sizing: border-box; font-weight: bold;">Proteinuria as a Surrogate for Kidney Failure Risk in FSGS</strong> - Jai Radhakrishnan</li>
<li style="box-sizing: border-box;"><strong style="box-sizing: border-box; font-weight: bold;">Selecting and Sequencing Therapy for FSGS: Past, Present, and Future</strong> - Vladimir Tesar</li>
</ul>
<br /><em style="box-sizing: border-box; color: #000000; font-family: 'Source Sans Pro', sans-serif; font-size: 14px; white-space: normal; background-color: #ffffff;">Support is provided by an educational grant from Travere Therapeutics, Inc.</em>

Asset Subtitle

Moderator(s): Astrid Weins

Presentation(s):

Introduction - Astrid Weins
Proteinuria as a Surrogate for Kidney Failure Risk in FSGS - Jai Radhakrishnan
Selecting and Sequencing Therapy for FSGS: Past, Present, and Future - Vladimir Tesar

Support is provided by an educational grant from Travere Therapeutics, Inc.

Meta Tag

Pathway(s) Glomerular Diseases

Pathway(s) CKD Non-Dialysis

Session Type ES - Educational Symposium

Speaker(s) Astrid Weins

Speaker(s) Jai Radhakrishnan

Speaker(s) Vladimir Tesar

Keywords

FSGS

proteinuria

kidney failure risk

surrogate marker

therapy selection

treatment sequencing

nephrology

Travere Therapeutics

glomerular disease

Astrid Weins